Data / Form D filings / Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc.: Form D filings
Eledon Pharmaceuticals, Inc., a biotechnology company in Irvine, CA, filed 8 Form D notices with the SEC between 2009 and 2024. The latest, on May 23, 2024, reports $50 million sold of an offering with no set size to 24 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 19800 MACARTHUR BLVD., SUITE 250, Irvine, CA, 92612
- Phone
- (949) 238-8090
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1404281
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 23, 2024 | New notice | Indefinite | $49,999,010 | 24 | May 9, 2024 | sec.gov | |
| May 22, 2023 | New notice | Indefinite | $35,000,000 | 38 | May 5, 2023 | sec.gov | |
| Sep 25, 2020 | New notice | $108,144,151 | $108,144,151 | 35 | Sep 15, 2020 | sec.gov | |
| Jan 27, 2020 | New notice | $5,828,999 | $862,278 | $4,966,721 | 10 | Jan 14, 2020 | sec.gov |
| May 10, 2019 | New notice | $28,455,174 | $862,278 | $27,592,896 | 10 | May 2, 2019 | sec.gov |
| May 15, 2013 | New notice | $35,499,985 | $19,999,993 | $15,499,992 | 19 | May 13, 2013 | sec.gov |
| Sep 20, 2011 | New notice | $22,999,986 | $1,892,794 | $21,107,192 | 6 | Sep 9, 2011 | sec.gov |
| May 6, 2009 | New notice | $22,000,000 | $10,000,000 | $12,000,000 | 10 | May 6, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steven Perrin | Executive Officer, Director | |
| David-Alexandre Gros | Executive Officer, Director | |
| June Lee | Director | |
| Allan Kirk | Director | |
| John McBride | Director | |
| James Robinson | Director | |
| Keith Katkin | Director | |
| Jan Hillson | Director | |
| Paul Little | Executive Officer | |
| Bryan Smith | Executive Officer | |
| Walter Ogier | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 20, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Eledon Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.